Explore 3 Stock Ideas & Industry Insights Download Free Report

News

ACI Worldwide (NASDAQ: ACIW) Expands Connetic Platform With Global Payment Network Integration

ACI Worldwide (NASDAQ: ACIW)is a Miami-based payments software company founded in 1975. It provides real-time payment, card, digital banking, and fraud management solutions to financial institutions, merchants, and billers in over 95 countries.

Team Kalkine | 27 May 2025

Diginex Limited (NASDAQ: DGNX) Signs Agreement to Acquire ESG Data Firm Matter DK ApS in All-Share Deal

Diginex Limited (NASDAQ: DGNX),a provider of sustainability regulatory technology solutions, announced on May 23, 2025, the signing of a Memorandum of Understanding (MOU) for the all-share acquisition of Matter DK ApS (“Matter”), an ESG data company based in Copenhagen, Denmark. The agreement outlines the …

Team Kalkine | 27 May 2025

Turkcell (NYSE: TKC) Secures $150M Murabaha Financing from Dubai Islamic Bank

Turkcell (NYSE: TKC, BIST: TCELL) Türkiye’s technology and communications provider, has signed a $150 million Murabaha financing agreement with Dubai Islamic Bank PJSC. The deal, based on Sharia-compliant interest-free financing principles, is structured as a five-year bullet maturity loan.

Team Kalkine | 26 May 2025

BioSig Technologies (Nasdaq: BSGM) Advances with Streamex Share Exchange Agreement; Targets $142.85 Trillion Commodity Market

BioSig Technologies, Inc. (Nasdaq: BSGM) has signed a definitive share exchange agreement with Streamex Exchange Corporation, a private company focused on tokenizing real-world assets, particularly commodities. The agreement will result in Streamex becoming a wholly owned subsidiary of BioSig through an exchange of Streamex …

Team Kalkine | 25 May 2025

Clean Energy Technologies (Nasdaq: CETY) Secures $4.4M Equity Investment in $85M European Solar and Wind Development Deal

Clean Energy Technologies, Inc. (Nasdaq: CETY) announced the signing of a Non-Binding Offer (NBO) with a European solar and wind development company, currently unnamed due to confidentiality. The agreement is part of a proposed transaction aimed at expanding CETY’s presence into the European renewable …

Team Kalkine | 25 May 2025

Moderna (NASDAQ: MRNA) Submits FDA Application for Spikevax 2025-2026 Targeting SARS-CoV-2 Variant LP.8.1

Moderna, Inc. (NASDAQ: MRNA) has submitted an application to the U.S. Food and Drug Administration (FDA) seeking review and authorization for its updated COVID-19 vaccine formula, Spikevax 2025-2026. The new formulation is designed specifically to target the SARS-CoV-2 variant LP.8.1.

Team Kalkine | 25 May 2025

IMUNON  (NASDAQ: IMNN) Announces $3.25Mn Private Placement and Potential $6.5Mn from Warrants

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, has entered into definitive agreements for a private placement involving the issuance and sale of 7,222,223 shares of its common stock—or pre-funded warrants in lieu thereof—along with short-term warrants to purchase up to 14,444,446 shares of …

Team Kalkine | 25 May 2025

eToro’s (NASDAQ: ETOR) FY24 Net Income Soars 1161% on Crypto Gains; Projects User Growth Amid EBITDA Headwinds in Q1

eToro Group Ltd (NASDAQ: ETOR)is a global financial platform founded in 2007. It offers retail access to stocks, commodities, currencies, and crypto assets. It features social investing tools like CopyTrader, Smart Portfolios, and a community network. Services include eToro Money, extended-hours trading, charting tools, …

Team Kalkine | 24 May 2025

Market Wrap-Up: Tariffs, Tax Uncertainty, and Commodity Volatility Drive Weekly Trends

Index Update:President Trump proposed a 50% tariff on EU imports and threatened a 25% tariff on Apple if it doesn't move iPhone production to the U.S., causing Apple shares to drop 4% in premarket trading. These trade tensions, combined with fiscal concerns following the …

Team Kalkine | 23 May 2025

Invivyd (Nasdaq: IVVD): PEMGARDA® Added to NCCN Guidelines, Targeting COVID-19 Risk in B-Cell Lymphoma Patients

Invivyd, Inc. (Nasdaq: IVVD) announced that its monoclonal antibody PEMGARDA® (pemivibart) has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas. The update identifies PEMGARDA as a potential pre-exposure prophylaxis (PrEP) option against COVID-19 for patients …

Team Kalkine | 23 May 2025